Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats

Bone

Volumn 44, Issue 5, 2009, Pages 942-947

  Han, XiaoLong ^a   Xu, YaJun ^a   Wang, JunBo ^a   Pei, XinRong ^a   Yang, RuiYue ^a   Li, Ning ^b   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

BMD; Cod bone gelatin; Osteoporosis; Ovariectomy; Trabecular microarchitecture

Indexed keywords

BIOCHEMICAL MARKER; COD BONE GELATIN; ESTRADIOL; GELATIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; REAL TIME POLYMERASE CHAIN REACTION; TIBIA; TRABECULAR BONE; UTERUS WEIGHT; WEIGHT GAIN;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; COLLAGEN TYPE I; ESTRADIOL; FEMALE; FEMUR; GELATIN; GENE EXPRESSION; INTERLEUKIN-1BETA; INTERLEUKIN-6; ORGAN SIZE; OSTEOCALCIN; OSTEOPROTEGERIN; OVARIECTOMY; POLYMERASE CHAIN REACTION; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 63449100431     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.12.005     Document Type: Article

References (36)

1. Alexander J.M., Bab I., Fish S., Muller R., Uchiyama T., Gronowicz G., et al. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J. Bone Miner. Res. 16 (2001) 1665-1673
2. Doherty D.A., Sanders K.M., Kotowicz M.A., and Prince R.L. Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos. Int. 12 (2001) 16-23
3. Adam M., Spacek P., Hulejova H., Galianova A., and Blahos J. Postmenopausal osteoporosis. Treatment with calcitonin and a diet rich in collagen proteins. Cas. Lek. Ces. 135 (1996) 74-78
4. Nomura Y., Oohashi K., Watanabe M., and Kasugai S. Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition 21 (2005) 1120-1126
5. Elzbieta Skierka M.S., and Karwowska A. Optimization of condition for demineralization Baltic cod (Gadus morhua) backbone. Food Chem. 105 (2007) 215-218
6. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
7. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
8. Tsuda E., Goto M., Mochizuki S., Yano K., Kobayashi F., Morinaga T., et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234 (1997) 137-142
9. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139 (1998) 1329-1337
10. Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W.J., Lacey D.L., and Riggs B.L. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111 (2003) 1221-1230
11. Shen V., Birchman R., Wu D.D., and Lindsay R. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. J. Bone Miner. Res. 15 (2000) 740-746
12. Mundy G.R. Bone resorption and turnover in health and disease. Bone 8 Suppl 1 (1987) S9-S16
13. Hanson N.A., and Bagi C.M. Alternative approach to assessment of bone quality using micro-computed tomography. Bone 35 (2004) 326-333
14. Hildebrand T., Laib A., Muller R., Dequeker J., and Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J. Bone Miner. Res. 14 (1999) 1167-1174
15. Odgaard A., and Gundersen H.J. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14 (1993) 173-182
16. Lark M.W., Stroup G.B., James I.E., Dodds R.A., Hwang S.M., Blake S.M., et al. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30 (2002) 746-753
17. Kalu D.N. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115 (1984) 507-512
18. van der Meulen M.C., Jepsen K.J., and Mikic B. Understanding bone strength: size isn't everything. Bone 29 (2001) 101-104
19. Seeman E. Bone quality: the material and structural basis of bone strength. J. Bone Miner. Metab. 26 (2008) 1-8
20. Ammann P., Bourrin S., Brunner F., Meyer J.M., Clement-Lacroix P., Baron R., et al. A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats. Bone 35 (2004) 153-161
21. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15 (1991) 175-191
22. Borah B., Dufresne T.E., Chmielewski P.A., Gross G.J., Prenger M.C., and Phipps R.J. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J. Bone Miner. Res. 17 (2002) 1139-1147
23. Ulrich D., van Rietbergen B., Laib A., and Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 (1999) 55-60
24. Muller R., Hannan M., Smith S.Y., and Bauss F. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. J. Bone Miner. Res. 19 (2004) 1787-1796
25. Lane N.E., Kumer J.L., Majumdar S., Khan M., Lotz J., Stevens R.E., et al. The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos. Int. 13 (2002) 816-823
26. Muller R., Koller B., Hildebrand T., Laib A., Gianolini S., and Ruegsegger P. Resolution dependency of microstructural properties of cancellous bone based on three-dimensional mu-tomography. Technol. Health Care 4 (1996) 113-119
27. Laib A., Barou O., Vico L., Lafage-Proust M.H., Alexandre C., and Rugsegger P. 3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med. Biol. Eng. Comput. 38 (2000) 326-332
28. Tanaka M., Toyooka E., Kohno S., Ozawa H., and Ejiri S. Long-term changes in trabecular structure of aged rat alveolar bone after ovariectomy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 95 (2003) 495-502
29. Ragab A.A., Nalepka J.L., Bi Y., and Greenfield E.M. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am. J. Physiol., Cell Physiol. 283 (2002) C679-C687
30. Azuma Y., Kaji K., Katogi R., Takeshita S., and Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275 (2000) 4858-4864
31. Kudo O., Sabokbar A., Pocock A., Itonaga I., Fujikawa Y., and Athanasou N.A. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32 (2003) 1-7
32. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., and Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106 (2000) 1481-1488
33. O'Brien C.A., Lin S.C., Bellido T., and Manolagas S.C. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines. J. Cell Biochem. 79 (2000) 532-541
34. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
35. Hakeda Y., Kobayashi Y., Yamaguchi K., Yasuda H., Tsuda E., Higashio K., et al. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem. Biophys. Res. Commun. 251 (1998) 796-801
36. Ikeda T., Utsuyama M., and Hirokawa K. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J. Bone Miner. Res. 16 (2001) 1416-1425